Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 8Unknown 7Completed 7Active not recruiting 5Not yet recruiting 3Terminated 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Myeloid 3Lymphoid 2

Conditions

Breast Neoplasms 544Neoplasms 384Carcinoma, Non-Small-Cell Lung 325Colorectal Neoplasms 296Lung Neoplasms 237Prostatic Neoplasms 220Carcinoma, Hepatocellular 213Stomach Neoplasms 155Pancreatic Neoplasms 155Leukemia, Myeloid, Acute 141Uterine Cervical Neoplasms 132Multiple Myeloma 130Recurrence 120Rectal Neoplasms 114Ovarian Neoplasms 109Neoplasm Metastasis 105Squamous Cell Carcinoma of Head and Neck 98Head and Neck Neoplasms 91Triple Negative Breast Neoplasms 87Esophageal Neoplasms 84Glioblastoma 82Endometrial Neoplasms 80Small Cell Lung Carcinoma 79Brain Neoplasms 79Colonic Neoplasms 78Melanoma 71Precursor Cell Lymphoblastic Leukemia-Lymphoma 65Hematologic Neoplasms 65Glioma 63Disease 60

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Lymphohistiocytosis, Hemophagocytic × Clear all
NCT06734624 2024-12-16

The Microbiome in Blood Cancer and HLH

University of Nottingham

Not yet recruiting
750 enrolled
LymphoidMyeloid

Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Lymphohistiocytosis, Hemophagocytic

NCT06131489 2023-11-14

Segmental Resection Combined With DEP Regimen for EBV-HLH Patients With Intestinal Involvement

Beijing Friendship Hospital

Not yet recruiting
20 enrolled
Myeloid

Epstein-Barr Virus Infections, Lymphohistiocytosis, Hemophagocytic

NCT05775705 2023-03-20

L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH

Beijing Friendship Hospital

Phase 3 Not yet recruiting
25 enrolled
LymphoidMyeloid

Lymphoma, Epstein-Barr Virus Infections, Lymphohistiocytosis, Hemophagocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡